AKRO Investors Have Opportunity to Lead Akero Therapeutics, Inc. Securities Fraud Lawsuit
AKROAkero(AKRO) prnewswire.com·2024-05-17 04:45

BENSALEM, Pa., May 16, 2024 /PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Akero Therapeutics, Inc. ("Akero" or the "Company") (NASDAQ: AKRO).Class Period: September 13, 2022 – October 9, 2023Lead Plaintiff Deadline: June 25, 2024Investors suffering losses on their Akero investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class ...